Doctor profile · Federal record
Dr. Vinh-Linh Nguyen, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Bakersfield, CA
- NPI 1285603639
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 28 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4500 Morning Dr Ste 105
Bakersfield, CA 933067276
(661) 491-5060
fax (661) 379-6363 - Mailing address
-
Po Box 21390
Bakersfield, CA 933901390
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- September 29, 2021
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- California #A99397 · Florida #ME 93227
- Medicaid
- FL #273185100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1285603639. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
383,729
Distinct HCPCS
10
Medicare allowed
$14,434,464
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9299 |
Injection, nivolumab, 1 mg | 74,400 | 29 | $27 | |
J9271 |
Injection, pembrolizumab, 1 mg | 50,801 | 33 | $54 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 48,900 | 16 | $12 | |
J9047 |
Injection, carfilzomib, 1 mg | 44,270 | 16 | $45 | |
J9145 |
Injection, daratumumab, 10 mg | 40,920 | 17 | $60 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 33,188 | 41 | $29 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 20,870 | 35 | $26 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 16,086 | 81 | $0 | |
J9228 |
Injection, ipilimumab, 1 mg | 14,300 | 15 | $145 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 6,789 | 74 | $0 |
In context: peer comparison
Among 3 peers in Bakersfield Hematology & Oncology Physician, average services per provider: 6,901. This provider delivers 56× the peer median.Open Payments
Industry payments received
All-time total
$294
Transactions
14
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | 3 | $76.97 | |
| Novartis Pharmaceuticals Corporation | 3 | $58.99 | |
| Pfizer INC. | 2 | $45.28 | |
| GlaxoSmithKline, LLC. | 1 | $26.57 | |
| Exelixis INC. | 1 | $24.90 | |
| Celgene Corporation | 1 | $19.45 | |
| Amneal Pharmaceuticals LLC | 1 | $15.94 | |
| Eisai INC. | 1 | $14.25 | |
| Gilead Sciences, INC. | 1 | $11.59 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,098
Patients
321
Total drug cost
$152,305
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 132 | 27 | $1,673 |
| Hydroxyurea | Generic | 103 | 18 | $1,728 |
| Anastrozole | Generic | 90 | 26 | $3,338 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 90 | 39 | $2,502 |
| Ondansetron Hcl | Generic | 89 | 48 | $2,474 |
| Morphine Sulfate ER (Morphine Sulfate) | Brand | 74 | 22 | $2,806 |
| Xarelto (Rivaroxaban) | Brand | 69 | 16 | $69,703 |
| Megestrol Acetate | Generic | 63 | 28 | $15,063 |
| Eliquis (Apixaban) | Brand | 60 | 19 | $45,606 |
| Prednisone | Generic | 60 | 30 | $321 |
Hospital affiliations
Frequently asked questions
What is Dr. Vinh-Linh Nguyen's medical specialty?
Dr. Vinh-Linh Nguyen practices Hematology & Oncology Physician in Bakersfield, CA.
Where does Dr. Vinh-Linh Nguyen practice?
Dr. Vinh-Linh Nguyen practices at 4500 Morning Dr Ste 105, Bakersfield, CA 933067276. Office phone: 6614915060.
What is Dr. Vinh-Linh Nguyen's NPI?
Dr. Vinh-Linh Nguyen's National Provider Identifier (NPI) is 1285603639, issued by NPPES.
Does Dr. Vinh-Linh Nguyen accept Medicare assignment?
Yes. Dr. Vinh-Linh Nguyen accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vinh-Linh Nguyen commonly perform?
Top Medicare-reported procedures in 2023: Injection, nivolumab, 1 mg (HCPCS J9299); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, paclitaxel protein-bound particles, 1 mg (HCPCS J9264). Source: CMS Medicare Physician & Other Practitioners file.